An official website of the United States government
Number of SEER-MHOS (1998-2021) Respondents (Age 65+) by First Cancer Site
| First Cancer (#) | Number of linked Patients with One or More survey (Group A) |
More than one survey* (Subset of Group A) |
Survey before Cancer Diagnosis (Group B) |
Survey both before and after Cancer Diagnosis** (Subset of Group B) |
Survey after Cancer Diagnosis (Group C) |
||||
|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | ||
| Prostate (28010) | 63,478 | 30,525 | (48.09) | 21,770 | (34.30) | 4,844 | (7.63) | 46,544 | (73.32) |
| Breast (26000) | 57,306 | 28,562 | (49.84) | 21,082 | (36.79) | 4,264 | (7.44) | 40,477 | (70.63) |
| Colorectal (21041-21052) | 34,179 | 16,178 | (47.33) | 16,362 | (47.87) | 2,451 | (7.17) | 20,264 | (59.29) |
| Lung and bronchus (22030) | 32,523 | 13,727 | (42.21) | 26,134 | (80.36) | 1,904 | (5.85) | 8,285 | (25.47) |
| Ovary (27040) | 3,282 | 1,511 | (46.04) | 2,032 | (61.91) | 194 | (5.91) | 1,444 | (44.00) |
| Uterus (27020, 27030) | 10,281 | 4,997 | (48.60) | 3,637 | (35.38) | 658 | (6.40) | 7,302 | (71.02) |
| Cervix (27010) | 1,461 | 638 | (43.67) | 464 | (31.76) | 50 | (3.42) | 1,047 | (71.66) |
| Bladder (29010) | 17,124 | 8,322 | (48.60) | 9,158 | (53.48) | 1,444 | (8.43) | 9,410 | (54.95) |
| Melanomas – skin (25010) | 17,714 | 9,238 | (52.15) | 8,277 | (46.73) | 1,469 | (8.29) | 10,865 | (61.34) |
| Head and Neck (20010-20100,22010,22020) | 8,181 | 3,694 | (45.15) | 3,973 | (48.56) | 578 | (7.07) | 4,786 | (58.50) |
| Kidney and Renal pelvis (29020) | 8,534 | 4,024 | (47.15) | 4,534 | (53.13) | 685 | (8.03) | 4,684 | (54.89) |
| Non-Hodgkin's lymphomas - nodal and extranodal (33041,33042) |
11,469 | 5,493 | (47.89) | 6,748 | (58.84) | 858 | (7.48) | 5,578 | (48.64) |
| Stomach (21020) | 4,254 | 1,814 | (42.64) | 3,064 | (72.03) | 246 | (5.78) | 1,435 | (33.73) |
| Pancreas (21100) | 6,506 | 2,764 | (42.48) | 5,978 | (91.88) | 216 | (3.32) | 744 | (11.44) |
* At least one survey must be two years after first survey.
** Number of individuals with a survey before their first cancer diagnosis and also a survey after their first cancer diagnosis.
Note:
- The denominator for the percentages that appear in columns 3 through 6 is the Number of linked patients with one or more survey by cancer site (column 2).
- The groups in columns 4 through 6 are not mutually exclusive, therefore, the percentages do not sum to 100.